Caffeine Citrate Injection Shortage

• • Caffeine Citrate injection, Caraco, 20 mg/mL, 3 mL 1 count, NDC 47335-0289-40

• • Caraco temporarily discontinued caffeine citrate injection.
  • Exela Pharma Sciences launched caffeine citrate intravenous injection in mid-2015.
  • Sagent states the reason for the shortage was manufacturing delays.
  • West-Ward has Cafcit 10 count presentations available. The company is not producing the 1 count presentation at this time to focus on the 10 count presentation.

• • Cafcit injection, West-Ward, 20 mg/mL, 3 mL vial, 10 count, NDC 00641-6164-10
  • Caffeine Citrate injection, American Regent, 20 mg/mL, 3 mL vial, 10 count, NDC 00517-0020-10
  • Caffeine Citrate injection, Exela Pharma Sciences, 20 mg/mL, 3 mL vial, 1 count, NDC 51754-0500-01
  • Caffeine Citrate injection, Fresenius Kabi, 20 mg/mL, 3 mL vial, 1 count, NDC 63323-0407-03
  • Caffeine Citrate injection, Sagent, 20 mg/mL, 3 mL 1 count, NDC 25021-0601-03

Estimated Resupply Dates

• • Caraco has temporarily discontinued caffeine citrate injection and the company cannot estimate when product will return.
  • All other marketed presentations are available.